Testing lumateperone for irritability in teens with autism
Part of Brain & nervous system, Mental health clinical trials.
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The child must be between 13 and 17 years old (currently only teens are being enrolled).
- They must have a confirmed autism diagnosis with significant irritability that affects daily life.
- A parent or guardian must be willing to take part in study visits and answer questions about the child.
- If the child has ADHD, their ADHD medications must have been stable for at least 30 days before the study starts.
- The child must not have serious thoughts of self-harm or suicide, and no diagnosis of Rett or Fragile X syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called Lumateperone to see if it can reduce irritability in children and teens with autism. It's a 3-month trial that compares the study drug to a placebo (a pill with no active medicine) to find out if it helps with mood and behavior.
This trial tests whether a combination of two medications (KarXT and KarX-EC) can help reduce irritability in children and teens with autism. It's for those who have significant irritability symptoms that affect daily life.
This trial tests a combination of two drugs, KarXT and KarX-EC, to see if they can reduce irritability in children and teens with autism spectrum disorder. If your child has significant irritability linked to their autism, this study may offer a new treatment option.
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
This study tests a new medication called lumateperone for treating depression in children and teens with bipolar disorder. It aims to see if this drug can help improve mood and daily functioning.
This trial tests a medication called lumateperone to see if it can improve apathy (lack of motivation) in people who have psychotic symptoms from schizophrenia or related disorders. It may help if you are already on a stable treatment but still struggle with apathy.
Hear when a new Irritability Associated With Autism Spectrum Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.